Northern Trust Corp Nrx Pharmaceuticals, Inc. Transaction History

Northern Trust Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$0.46 - $0.89 $1,727 - $3,341	3,755 Added 5.27%	74,996 $35,000
Q1 2023 May 15, 2023	BUY	$0.66 - $1.4 $8,344 - $17,700	12,643 Added 21.58%	71,241 $47,000
Q1 2022 May 13, 2022	BUY	$2.45 - $5.04 $54,688 - $112,502	22,322 Added 61.53%	58,598 $144,000
Q4 2021 Feb 08, 2022	BUY	$4.5 - $11.91 $163,242 - $432,047	36,276 New	36,276 $173,000
Q3 2021 Nov 15, 2021	SELL	$8.52 - $24.77 $1.11 Million - $3.24 Million	-130,633 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$11.62 - $44.5 $1.52 Million - $5.81 Million	130,633 New	130,633 $1.52 Million

17.4K

Ticker NRXP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,641,296
Market Cap $101M
Description
NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-10...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.